Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 290650148 approvals9 trials

L&C BIO Co., Ltd

Official website

L&C BIO manufactures human tissue grafts across 11 tissue types, including the acellular dermal matrix MegaDerm, plus tissue-based medical devices.

As of 2026-10-11, L&C BIO Co., Ltd has 23 Korean MFDS device approvals, 125 Korean MFDS drug approvals, 10 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2011, L&C BIO listed on KOSDAQ in 2018 as a company specializing in human tissue grafts and tissue-based medical devices. It produces human tissue grafts across 11 tissue types—bone, cartilage, fascia, skin, amniotic membrane, ligament, tendon, heart valve, blood vessel, nerve, and pericardium—under MFDS approval; its flagship product, the acellular dermal matrix (ADM) MegaDerm, is used for breast reconstruction after cancer treatment, and it also manufactures and exports tissue-based medical devices such as MegaDBM S, MegaCure, MegaShield, and MegaCarti. It is developing a broad follow-on pipeline including MegaNerve Prime (peripheral nerve replacement, co-developed with Czech firm PrimeCell), MegaFill Putty and TendonFill (pending process validation), and Mega3DEar, MegaAdipo ECM, and ZAG peptide (pending clinical trials).

Products & technology

  • MegaDermAcellular dermal matrix for breast reconstruction after cancer treatment
  • MegaDerm SoftSubstitute for defective human skin
  • MegaFill Hi-jectArthritis, disc, and fasciitis of the spine, shoulder, neck, and cartilage
  • MegaNerve PrimeReplacement for damaged peripheral nerves (peripheral neuropathy, nerve loss)
  • ES.FillSubstitute for defective human skin and skin regeneration
  • MegaDBM SOrthopedic and dental implant material replacing bone loss from trauma or osteoporosis
  • MegaCureBioabsorbable wound dressing for trauma and chronic open wounds
  • MegaShieldAnti-adhesion barrier reducing adhesion after thyroid surgery
  • MegaCartiCollagen-based tissue filler for focal knee cartilage defects and degenerative arthritis
  • Mega Cartilage-ETissue-repair biomaterial for rhinoplasty
  • MegaCare WNon-absorbable wound dressing for burns, skin graft sites, and foot ulcers

Regulatory approvals

data.go.kr

125 Korean MFDS drug approvals · 2008–2024 / 23 Korean MFDS device approvals · 2011–2023

  • MFDS drugMegatantan tablet 20mg2024-07-30
    Drug · Prescription · Approval202401842
  • MFDS drugMegatantan tablet 5mg2024-07-30
    Drug · Prescription · Approval202401843
  • MFDS drugMega Rosutin Tab. 2.5mg2024-06-13
    Drug · Prescription · Approval202401442
  • MFDSTissue supplement, collagen2023-12-05
    Product approval · Class 4제허 23-1109 호
  • MFDS drugacepherin Tab2022-12-09
    Drug · OTC · Notification202204455
  • MFDSTissue supplement, collagen2022-11-15
    Product approval · Class 4제허 22-760 호
  • MFDSGraft/prosthesis, biomaterial2022-06-07
    Product approval · Class 4제허 22-368 호
  • MFDS drugFloxetine capsule (Fluoxetine hydrochloride)2022-01-11
    Drug · Prescription · Approval202200244
  • MFDS drugDabiu Tab2021-12-29
    Drug · OTC · Notification202108189
  • MFDSGraft/prosthesis, biomaterial2021-12-28
    Product approval · Class 4제허 21-1044 호
  • MFDS drugMupicin Ointment(Mupirocin)2021-10-20
    Drug · OTC · Notification202107041
  • MFDS drugVeni-F Tab2021-09-24
    Drug · OTC · Notification202106639
Show 68 more
  • MFDS drugMomentasol Cream(Mometasone Furoate)2021-09-10
    Drug · Prescription · Notification202106493
  • MFDSDressing, non-absorbable, wound, biological synthetic2021-06-24
    Product approval · Class 4제허 21-519 호
  • MFDSDressing, adhesion barrier2021-03-15
    Product approval · Class 3제허 21-189 호
  • MFDS drugMegabromel TabletRevoked2021-02-23
    Drug · OTC · Notification202101789
  • MFDS drugL&C Megapen Tab.2020-10-06
    Drug · OTC · Notification202006755
  • MFDSDressing, absorbable, wound, biological origin2020-09-17
    Product approval · Class 4제허 20-819 호
  • MFDSBone graft, human source2020-07-15
    Product approval · Class 4제허 20-575 호
  • MFDS drugMega Sarpo SR Tab. 300mg2020-05-21
    Drug · Prescription · Approval202003677
  • MFDS drugEsome Tab. 20mg2020-05-21
    Drug · Prescription · Approval202003714
  • MFDS drugMegatra Cap.2020-05-18
    Drug · Prescription · Approval202003621
  • MFDS drugMega Solfena Tab. 5mg2020-05-15
    Drug · Prescription · Approval202003532
  • MFDS drugMega Solfena Tab. 10mgRevoked2020-05-15
    Drug · Prescription · Approval202003533
  • MFDS drugMegatelmichle Tab. 80/12.5mg2020-04-27
    Drug · Prescription · Approval202003085
  • MFDS drugMega Acedol Semi Tab.2020-04-22
    Drug · Prescription · Approval202002850
  • MFDS drugMega Acedol Tab.2020-04-16
    Drug · Prescription · Approval202002678
  • MFDS drugMega Gli Tab. 4mgRevoked2020-04-13
    Drug · Prescription · Approval202002589
  • MFDS drugrabenda Tab 10mg2020-04-06
    Drug · Prescription · Approval202002384
  • MFDS drugrabenda Tab 20mg2020-04-06
    Drug · Prescription · Approval202002385
  • MFDS drugOlmetan Tab. 40mg2020-03-31
    Drug · Prescription · Approval202002233
  • MFDS drugOlmetan Tab. 10mg2020-03-31
    Drug · Prescription · Approval202002234
  • MFDS drugMega Pio Tab. 15mg2020-03-27
    Drug · Prescription · Approval202002149
  • MFDS drugMega Katihub Tab.Revoked2020-03-26
    Drug · Prescription · Notification202002120
  • MFDS drugMega Vartan Tab. 160mgRevoked2020-03-25
    Drug · Prescription · Approval202002082
  • MFDS drugMega Palo Inj.Revoked2020-03-20
    Drug · Prescription · Approval202001990
  • MFDS drugMega Gli Tab. 2mgRevoked2020-03-19
    Drug · Prescription · Approval202001916
  • MFDS drugMega Octylo Tab. 40mgRevoked2020-03-19
    Drug · Prescription · Approval202001923
  • MFDS drugMegaclofenac Tab.2020-03-18
    Drug · Prescription · Approval202001890
  • MFDS drugTamsurosin SR Tab. 0.2mg(Tamsulosin Hydrochloride)2020-03-17
    Drug · Prescription · Approval202001874
  • MFDS drugMega Pivatin Tab. 2mgRevoked2020-03-17
    Drug · Prescription · Approval202001859
  • MFDS drugMega Duta Soft Cap. 0.5mgRevoked2020-03-16
    Drug · Prescription · Approval202001802
  • MFDS drugMega Vartan Tab. 80mg2020-03-10
    Drug · Prescription · Approval202001651
  • MFDS drugMega Oflox Tab.Revoked2020-03-10
    Drug · Prescription · Approval202001652
  • MFDS drugMega Alend Tab.Revoked2020-03-10
    Drug · Prescription · Approval202001654
  • MFDS drugMega Coxib Cap. 200mg2020-03-06
    Drug · Prescription · Approval202001572
  • MFDS drugMegatelmichle Tab. 40/12.5mg2020-03-04
    Drug · Prescription · Approval202001518
  • MFDS drugMega Fudine Tab.Revoked2020-03-04
    Drug · Prescription · Approval202001514
  • MFDS drugMega Diace Cap. 50mgRevoked2020-02-28
    Drug · Prescription · Approval202001423
  • MFDS drugMega Prega Cap. 75mg2020-02-27
    Drug · Prescription · Approval202001371
  • MFDS drugMega Prega Cap. 150mg2020-02-27
    Drug · Prescription · Approval202001372
  • MFDS drugMega Fesia Tab. 5mg2020-02-25
    Drug · Prescription · Approval202001337
  • MFDS drugMega Acedol Semi SR Tab.Revoked2020-02-24
    Drug · Prescription · Approval202001289
  • MFDS drugMega Acedol SR Tab.Revoked2020-02-24
    Drug · Prescription · Approval202001290
  • MFDS drugEsome Tab. 40mg2020-02-21
    Drug · Prescription · Approval202001244
  • MFDS drugMega Febuk Tab. 40mgRevoked2020-02-21
    Drug · Prescription · Approval202001263
  • MFDS drugMega Amlopine Tab.Revoked2020-02-20
    Drug · Prescription · Approval202001202
  • MFDS drugMega Febuk Tab. 80mgRevoked2020-02-20
    Drug · Prescription · Approval202001229
  • MFDS drugMega Mipide Tab.2020-02-18
    Drug · Prescription · Approval202001113
  • MFDS drugMega Sarpo Tab. 100mg2020-02-18
    Drug · Prescription · Approval202001115
  • MFDS drugMega Coxib Cap. 100mg2020-02-17
    Drug · Prescription · Approval202001044
  • MFDS drugMega Simvatin Tab.Revoked2020-02-17
    Drug · Prescription · Approval202001045
  • MFDS drugMega Tra Tab.Revoked2020-02-17
    Drug · Prescription · Approval202001047
  • MFDS drugMega Rosatanchle TabRevoked2020-02-17
    Drug · Prescription · Approval202001070
  • MFDS drugMega Loxicam Cap. 7.5mg2020-02-13
    Drug · Prescription · Approval202000927
  • MFDS drugMega Loxicam Cap. 15mgRevoked2020-02-13
    Drug · Prescription · Approval202000928
  • MFDS drugMega Batin Cap. 300mg2020-02-11
    Drug · Prescription · Approval202000804
  • MFDS drugMega Batin Cap. 100mg2020-02-11
    Drug · Prescription · Approval202000805
  • MFDS drugMega Cilozol Tab.Revoked2020-02-11
    Drug · Prescription · Approval202000814
  • MFDS drugMega Simvae Tab. 10/10mgRevoked2020-02-10
    Drug · Prescription · Approval202000774
  • MFDS drugMega Lesulpi Tab.2020-02-07
    Drug · Prescription · Approval202000716
  • MFDS drugMega Rosutin Tab. 5mg2020-02-06
    Drug · Prescription · Approval202000698
  • MFDS drugMega Famo Tab. 20mg2020-02-04
    Drug · Prescription · Approval202000592
  • MFDS drugMega Omezole Cap. 20mgRevoked2020-02-04
    Drug · Prescription · Approval202000587
  • MFDS drugMega Glimet Tab. 1/250mgRevoked2020-02-04
    Drug · Prescription · Approval202000589
  • MFDS drugMega Glimet Tab. 2/500mgRevoked2020-02-04
    Drug · Prescription · Approval202000590
  • MFDS drugMega Ezeti Tab. 10mgRevoked2020-02-04
    Drug · Prescription · Approval202000591
  • MFDS drugMega Telmi Tab. 80mg2020-01-28
    Drug · Prescription · Approval202000419
  • MFDS drugMega Telmi Tab. 40mg2020-01-28
    Drug · Prescription · Approval202000420
  • MFDS drugMega Losatan Tab.2020-01-21
    Drug · Prescription · Approval202000343

Showing the 80 most recent of 148 records.

Clinical trials

data.go.kr

9 MFDS clinical trial authorisations · 2022–2026 (Bioequivalence 9)

  • BioequivalenceLNC26012026-04-01

    1 trial site

  • Bioequivalence메가프리드정(모사프리드시트르산염수화물)2022-08-08

    1 trial site

  • Bioequivalence메가에스틴정2022-04-11

    1 trial site

  • Bioequivalence메가터빈정2022-03-25

    1 trial site

  • Bioequivalence메가플나졸캡슐2022-03-17

    1 trial site

  • Bioequivalence메가클로피정75밀리그램2022-02-25

    1 trial site

  • Bioequivalence메가로수틴정20밀리그램2022-02-16

    1 trial site

  • Bioequivalence메가팜시버정(팜시클로비르)2022-02-03

    1 trial site

  • Bioequivalence도네페진정10밀리그램2022-01-18

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

MegaFill Putty · 유방 등 연조직 절제 후 조직재건 · 공정밸리데이션 예정(2023 연구시작, 대한민국) · In-house development by L&C BIO

TendonFill · 인체 건/인대 손상 · 공정밸리데이션 예정(2023 연구시작, 대한민국) · In-house development by L&C BIO

Sheet type MegaFill · 화상, 외상 등으로 인한 피부 결손 · 제형 개발중(2025 연구시작, 대한민국) · In-house development by L&C BIO

MegaDerm Soft FD type · 개두술 후 손상된 연조직 보강 · 제형 개발중(2025 연구시작, 대한민국) · In-house development by L&C BIO

포켓형 ADM · 유방재건술에서 보형물 삽입 시 연부조직 보강 및 지지 · 제형 개발중(2025 연구시작, 대한민국) · In-house development by L&C BIO

MegaPlug · 발치 후 치조골 결손부 이식 재생유도 · 공정밸리데이션 예정(2024 연구시작, 대한민국) · In-house development by L&C BIO

MegaAdipo ECM · 안면성형 및 바디필러 · 임상 예정(2018 연구시작, 대한민국) · Tissue-repair biomaterial, in-house development by L&C BIO

Mega3DEar · 소이증 환자 귀 재건 · 임상 예정(2019 연구시작, 대한민국) · Designated orphan medical device, in-house development by L&C BIO

ZAG peptide · 아토피 피부염 및 상처 흔적 관련 피부질환 · 임상 예정(2018 연구시작, 대한민국) · In-house development by L&C BIO

ES.Stat · 출혈 부위의 지혈 · 개발중(2023 연구시작, 대한민국) · Absorbable internal hemostatic product, in-house development by L&C ES

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 63 more patents

AI reads

MAA server logs · IP-verified
112
Times AI engines pulled L&C BIO Co., Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

109
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

14
live 2
Last 7 days
83
live 2
Last 30 days
112
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot94
  • GoogleGoogleOther11
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for L&C BIO Co., Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HANS BIOMED CORPORATION5 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

CELLUMED CO., LTD.4 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

SHINHUNG CO.,LTD3 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

BNC KOREA, Inc.3 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

SEJONG MEDICAL Co.Ltd.,2 shared

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

L&K BIOMED CO., LTD.2 shared

Spinal implant device maker founded 2008, listed on KOSDAQ 2016; produces Cervical and Thoraco Lumbar Cage, Screw, and Plate products.

CG MedTech Co.,Ltd.2 shared

Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.

MEDYSSEY CO.,LTD2 shared

Manufactures spinal implants and metal 3D-printed patient-specific implants, exporting to over 25 countries.

PharmaResearch Co., Ltd.2 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

Alpha AI Co.,Ltd.2 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

Humedix Co., Ltd.2 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

DENTIS CO.,LTD2 shared

Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition